Cargando…

Explainable AI in Diagnosing and Anticipating Leukemia Using Transfer Learning Method

White blood cells (WBCs) are blood cells that fight infections and diseases as a part of the immune system. They are also known as “defender cells.” But the imbalance in the number of WBCs in the blood can be hazardous. Leukemia is the most common blood cancer caused by an overabundance of WBCs in t...

Descripción completa

Detalles Bibliográficos
Autores principales: Abir, Wahidul Hasan, Uddin, Md. Fahim, Khanam, Faria Rahman, Tazin, Tahia, Khan, Mohammad Monirujjaman, Masud, Mehedi, Aljahdali, Sultan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9068323/
https://www.ncbi.nlm.nih.gov/pubmed/35528341
http://dx.doi.org/10.1155/2022/5140148
_version_ 1784700201419669504
author Abir, Wahidul Hasan
Uddin, Md. Fahim
Khanam, Faria Rahman
Tazin, Tahia
Khan, Mohammad Monirujjaman
Masud, Mehedi
Aljahdali, Sultan
author_facet Abir, Wahidul Hasan
Uddin, Md. Fahim
Khanam, Faria Rahman
Tazin, Tahia
Khan, Mohammad Monirujjaman
Masud, Mehedi
Aljahdali, Sultan
author_sort Abir, Wahidul Hasan
collection PubMed
description White blood cells (WBCs) are blood cells that fight infections and diseases as a part of the immune system. They are also known as “defender cells.” But the imbalance in the number of WBCs in the blood can be hazardous. Leukemia is the most common blood cancer caused by an overabundance of WBCs in the immune system. Acute lymphocytic leukemia (ALL) usually occurs when the bone marrow creates many immature WBCs that destroy healthy cells. People of all ages, including children and adolescents, can be affected by ALL. The rapid proliferation of atypical lymphocyte cells can cause a reduction in new blood cells and increase the chances of death in patients. Therefore, early and precise cancer detection can help with better therapy and a higher survival probability in the case of leukemia. However, diagnosing ALL is time-consuming and complicated, and manual analysis is expensive, with subjective and error-prone outcomes. Thus, detecting normal and malignant cells reliably and accurately is crucial. For this reason, automatic detection using computer-aided diagnostic models can help doctors effectively detect early leukemia. The entire approach may be automated using image processing techniques, reducing physicians' workload and increasing diagnosis accuracy. The impact of deep learning (DL) on medical research has recently proven quite beneficial, offering new avenues and possibilities in the healthcare domain for diagnostic techniques. However, to make that happen soon in DL, the entire community must overcome the explainability limit. Because of the black box operation's shortcomings in artificial intelligence (AI) models' decisions, there is a lack of liability and trust in the outcomes. But explainable artificial intelligence (XAI) can solve this problem by interpreting the predictions of AI systems. This study emphasizes leukemia, specifically ALL. The proposed strategy recognizes acute lymphoblastic leukemia as an automated procedure that applies different transfer learning models to classify ALL. Hence, using local interpretable model-agnostic explanations (LIME) to assure validity and reliability, this method also explains the cause of a specific classification. The proposed method achieved 98.38% accuracy with the InceptionV3 model. Experimental results were found between different transfer learning methods, including ResNet101V2, VGG19, and InceptionResNetV2, later verified with the LIME algorithm for XAI, where the proposed method performed the best. The obtained results and their reliability demonstrate that it can be preferred in identifying ALL, which will assist medical examiners.
format Online
Article
Text
id pubmed-9068323
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-90683232022-05-05 Explainable AI in Diagnosing and Anticipating Leukemia Using Transfer Learning Method Abir, Wahidul Hasan Uddin, Md. Fahim Khanam, Faria Rahman Tazin, Tahia Khan, Mohammad Monirujjaman Masud, Mehedi Aljahdali, Sultan Comput Intell Neurosci Research Article White blood cells (WBCs) are blood cells that fight infections and diseases as a part of the immune system. They are also known as “defender cells.” But the imbalance in the number of WBCs in the blood can be hazardous. Leukemia is the most common blood cancer caused by an overabundance of WBCs in the immune system. Acute lymphocytic leukemia (ALL) usually occurs when the bone marrow creates many immature WBCs that destroy healthy cells. People of all ages, including children and adolescents, can be affected by ALL. The rapid proliferation of atypical lymphocyte cells can cause a reduction in new blood cells and increase the chances of death in patients. Therefore, early and precise cancer detection can help with better therapy and a higher survival probability in the case of leukemia. However, diagnosing ALL is time-consuming and complicated, and manual analysis is expensive, with subjective and error-prone outcomes. Thus, detecting normal and malignant cells reliably and accurately is crucial. For this reason, automatic detection using computer-aided diagnostic models can help doctors effectively detect early leukemia. The entire approach may be automated using image processing techniques, reducing physicians' workload and increasing diagnosis accuracy. The impact of deep learning (DL) on medical research has recently proven quite beneficial, offering new avenues and possibilities in the healthcare domain for diagnostic techniques. However, to make that happen soon in DL, the entire community must overcome the explainability limit. Because of the black box operation's shortcomings in artificial intelligence (AI) models' decisions, there is a lack of liability and trust in the outcomes. But explainable artificial intelligence (XAI) can solve this problem by interpreting the predictions of AI systems. This study emphasizes leukemia, specifically ALL. The proposed strategy recognizes acute lymphoblastic leukemia as an automated procedure that applies different transfer learning models to classify ALL. Hence, using local interpretable model-agnostic explanations (LIME) to assure validity and reliability, this method also explains the cause of a specific classification. The proposed method achieved 98.38% accuracy with the InceptionV3 model. Experimental results were found between different transfer learning methods, including ResNet101V2, VGG19, and InceptionResNetV2, later verified with the LIME algorithm for XAI, where the proposed method performed the best. The obtained results and their reliability demonstrate that it can be preferred in identifying ALL, which will assist medical examiners. Hindawi 2022-04-27 /pmc/articles/PMC9068323/ /pubmed/35528341 http://dx.doi.org/10.1155/2022/5140148 Text en Copyright © 2022 Wahidul Hasan Abir et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Abir, Wahidul Hasan
Uddin, Md. Fahim
Khanam, Faria Rahman
Tazin, Tahia
Khan, Mohammad Monirujjaman
Masud, Mehedi
Aljahdali, Sultan
Explainable AI in Diagnosing and Anticipating Leukemia Using Transfer Learning Method
title Explainable AI in Diagnosing and Anticipating Leukemia Using Transfer Learning Method
title_full Explainable AI in Diagnosing and Anticipating Leukemia Using Transfer Learning Method
title_fullStr Explainable AI in Diagnosing and Anticipating Leukemia Using Transfer Learning Method
title_full_unstemmed Explainable AI in Diagnosing and Anticipating Leukemia Using Transfer Learning Method
title_short Explainable AI in Diagnosing and Anticipating Leukemia Using Transfer Learning Method
title_sort explainable ai in diagnosing and anticipating leukemia using transfer learning method
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9068323/
https://www.ncbi.nlm.nih.gov/pubmed/35528341
http://dx.doi.org/10.1155/2022/5140148
work_keys_str_mv AT abirwahidulhasan explainableaiindiagnosingandanticipatingleukemiausingtransferlearningmethod
AT uddinmdfahim explainableaiindiagnosingandanticipatingleukemiausingtransferlearningmethod
AT khanamfariarahman explainableaiindiagnosingandanticipatingleukemiausingtransferlearningmethod
AT tazintahia explainableaiindiagnosingandanticipatingleukemiausingtransferlearningmethod
AT khanmohammadmonirujjaman explainableaiindiagnosingandanticipatingleukemiausingtransferlearningmethod
AT masudmehedi explainableaiindiagnosingandanticipatingleukemiausingtransferlearningmethod
AT aljahdalisultan explainableaiindiagnosingandanticipatingleukemiausingtransferlearningmethod